LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 228 filers reported holding LOXO ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $25,447,000 | -12.2% | 181,675 | +7.1% | 12.65% | +6.3% |
| Q3 2018 | $28,986,000 | +5.3% | 169,675 | +6.9% | 11.90% | -7.6% |
| Q2 2018 | $27,527,000 | +31.4% | 158,675 | -12.6% | 12.89% | +26.5% |
| Q1 2018 | $20,944,000 | -15.9% | 181,537 | -38.7% | 10.19% | -24.1% |
| Q4 2017 | $24,917,000 | +3.2% | 296,000 | +12.9% | 13.42% | -10.5% |
| Q3 2017 | $24,147,000 | -0.8% | 262,121 | -13.7% | 14.99% | -13.7% |
| Q2 2017 | $24,347,000 | +92.4% | 303,621 | +1.0% | 17.37% | +62.3% |
| Q1 2017 | $12,654,000 | +182.0% | 300,722 | +115.2% | 10.70% | +171.5% |
| Q4 2016 | $4,487,000 | +31.6% | 139,722 | +7.3% | 3.94% | +66.0% |
| Q3 2016 | $3,409,000 | +44.2% | 130,222 | +27.7% | 2.37% | +26.7% |
| Q2 2016 | $2,364,000 | +121.8% | 101,966 | +161.5% | 1.87% | +103.7% |
| Q1 2016 | $1,066,000 | -39.3% | 39,000 | -36.8% | 0.92% | -41.2% |
| Q4 2015 | $1,756,000 | +756.6% | 61,737 | +425.6% | 1.56% | +670.9% |
| Q3 2015 | $205,000 | -7.2% | 11,745 | -4.1% | 0.20% | +8.6% |
| Q2 2015 | $221,000 | – | 12,245 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|